Can listening to music reduce pain and anxiety after lung cancer surgery?

ISRCTN ISRCTN31401365
DOI https://doi.org/10.1186/ISRCTN31401365
Sponsor Cyprus University of Technology
Funder Investigator initiated and funded
Submission date
15/09/2026
Registration date
16/09/2026
Last edited
15/09/2026
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Surgery is a common treatment for lung cancer, but many patients experience pain, anxiety, and stress during their recovery. Medicines can help manage these symptoms, but additional non-drug approaches may also be beneficial. Listening to music has been suggested as a simple and inexpensive way to improve wellbeing and reduce discomfort in patients undergoing medical treatment. This study aims to investigate whether listening to relaxing music after thoracic surgery can reduce pain and anxiety in patients with lung cancer. The study also examines the effects of music on stress levels, vital signs, the need for additional pain medication, and levels of a substance involved in pain signalling called Substance P.

Who can participate?
Adults aged 18 to 75 years with lung cancer who are undergoing thoracic surgery and are able to speak Greek can take part.

What does the study involve?
Participants are allocated to one of two groups. Both groups receive standard postoperative care and medication. In addition, participants in the intervention group listen to 30 minutes of pre-recorded relaxing instrumental music through headphones once a day during their hospital stay, starting on the first day after surgery. Participants in the control group rest during the same period but do not listen to music. Researchers assess pain, anxiety, stress levels, blood pressure, heart rate, and the use of additional pain medication. Levels of Substance P are also measured in participants receiving the music intervention. The results are compared to determine whether music listening improves recovery after surgery.

What are the possible benefits and risks of participating?
Participants who listen to music may experience reduced pain, anxiety, or stress during their recovery. The findings may help improve supportive care for patients recovering from lung cancer surgery. Risks are expected to be minimal, although some participants may find listening to music through headphones uncomfortable or may not enjoy the selected music. Participants in the intervention group also undergo blood sampling to measure Substance P levels.

Where is the study run from?
The study is run at the Theagenio Cancer Hospital of Thessaloniki – Thoracic Oncology Surgery Department, Thessaloniki, Greece.

When is the study starting and how long is it expected to run for?
The study started recruiting participants in December 2025 and recruitment ended in March 2026. The study was completed in March 2026.

Who is funding the study?
The study is investigator-initiated and investigator-funded. The sponsor is Cyprus University of Technology.

Who is the main contact?
Dr Maria Chochou, mariachochou@gmail.com.

Contact information

Dr Maria Chochou
Public, Scientific, Principal investigator

Tenedou 44
4th floor
Thessaloniki
54453
Greece

Phone +306943473583
Email mariachochou@gmail.com

Study information

Primary study designInterventional
AllocationNon-randomized controlled trial
MaskingOpen (masking not used)
ControlActive
AssignmentParallel
PurposeSupportive care
Scientific titleThe effect of Music Medicine on postoperative pain and anxiety in patients with lung cancer undergoing thoracic surgery
Study objectives The aim of the study was to investigate the effect of music listening (Music Medicine) on postoperative pain and anxiety in patients with lung cancer undergoing thoracic surgery. Secondary objectives were to investigate its effects on perceived stress, vital signs, additional analgesic use and Substance P levels.
Ethics approval(s)

Approved 29/05/2025, Scientific Council and Board of Directors of Theagenio Cancer Hospital of Thessaloniki (2 Alexandrou Simeonidi Street, Thessaloniki, 54639, Greece; +30 2313301848; theagenio@otenet.gr), ref: 16/29.05.2025

Health condition(s) or problem(s) studiedPostoperative pain and anxiety in patients with lung cancer undergoing thoracic surgery
InterventionParticipants were allocated to either an intervention group or a control group using a non-randomized design. Both groups received standard postoperative care and pharmacological treatment.

Participants in the intervention group additionally listened to 30 minutes of pre-recorded classical, soft, relaxing instrumental music without vocals, with a tempo of 60–80 beats per minute. Music listening was conducted once daily between 15:30 and 16:30, starting on the first postoperative day and continuing until the day before hospital discharge. Participants listened through headphones and were allowed to adjust the volume.

Participants in the control group received standard postoperative care without music listening. During the corresponding assessment period, they followed the same resting conditions as the intervention group but did not listen to music and did not undergo blood sampling for Substance P measurement. Outcomes were assessed before and after the intervention/rest period during the postoperative period.
Intervention typeBehavioural
Primary outcome measure(s)
  1. Postoperative pain measured using a Visual Analogue Scale (VAS) at baseline preoperatively and daily at 15:30 and 16:30 from postoperative day 1 until the day before hospital discharge
  2. Postoperative state anxiety measured using State subscale of the State-Trait Anxiety Inventory (STAI-S) at Baseline preoperatively and daily between 15:30 and 16:30 from postoperative day 1 until the day before hospital discharge
Key secondary outcome measure(s)
  1. Perceived stress measured using the Perceived Stress Scale (PSS-10) at baseline preoperatively and on the day of hospital discharge
  2. Additional postoperative analgesic use measured using data recording of whether each participant received at least one additional dose of analgesic medication at the postoperative period until hospital discharge
  3. Vital signs, including systolic blood pressure (SBP), diastolic blood pressure (DBP) and heart rate (pulse), measured using standard methods at baseline preoperatively and daily between 15:30 and 16:30 from postoperative day 1 until the day before hospital discharge
  4. Serum Substance P levels measured using Enzyme-linked immunosorbent assay (ELISA) in the intervention group at a daily time points before and after the music listening intervention from postoperative day 1 until the day before hospital discharge
Completion date22/03/2026

Eligibility

Participant type(s)
Age groupMixed
Lower age limit18 Years
Upper age limit75 Years
SexAll
Target sample size at registration30
Total final enrolment30
Key inclusion criteria1. Patients diagnosed with lung cancer
2. Patients undergoing thoracic surgery via thoracotomy or video-assisted thoracoscopic surgery (VATS)
3. Aged 18 to 75 years
4. Able to speak Greek
Key exclusion criteria1. Hearing impairment (e.g. requiring the use of a hearing aid)
2. Unwillingness to participate in the study
3. Postoperative complications requiring repeat surgery
Date of first enrolment05/12/2025
Date of final enrolment18/03/2026

Locations

Countries of recruitment

  • Greece

Study participating centre

Theagenio Cancer Hospital of Thessaloniki – Thoracic Oncology Surgery Department
2 Alexandrou Simeonidi Street
Thessaloniki
54639
Greece

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

15/09/2026: Study’s existence confirmed by the Scientific Council and Board of Directors of Theagenio Cancer Hospital of Thessaloniki, Greece.